Immune reactivity during COVID-19: Implications for treatment

Baricitinib as potential treatment for 2019-nCoV acute respiratory disease

(2020) Peter Richardson et al.   LANCET

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

(2020) Roujian Lu et al.   LANCET

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

(2020) Nanshan Chen et al.   LANCET

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

A pneumonia outbreak associated with a new coronavirus of probable bat origin

(2020) Peng Zhou et al.   NATURE

Clinical Characteristics of Coronavirus Disease 2019 in China

(2020) Wei-jie Guan et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Novel Coronavirus from Patients with Pneumonia in China, 2019

(2020) Na Zhu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Hematological findings and complications of COVID ‐19

(2020) Evangelos Terpos et al.   AMERICAN JOURNAL OF HEMATOLOGY

Severe Acute Respiratory Syndrome Coronavirus 2 Infection and the Upper Limb Deep Vein Thrombosis Risk

(2020) Antonio Bozzani et al.   ANNALS OF VASCULAR SURGERY

Thromboembolic risk and anticoagulant therapy in COVID‐19 patients: emerging evidence and call for action

(2020) Anastasios Kollias et al.   BRITISH JOURNAL OF HAEMATOLOGY

Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure

(2020) Evangelos J. Giamarellos-Bourboulis et al.   Cell Host & Microbe

Prominent changes in blood coagulation of patients with SARS-CoV-2 infection

(2020) Huan Han et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019

(2020) Juanjuan Zhao et al.   CLINICAL INFECTIOUS DISEASES

Immunology of COVID-19: current state of the science

(2020) Nicolas Vabret et al.   IMMUNITY

High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study

(2020) Julie Helms et al.   INTENSIVE CARE MEDICINE

Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma

(2020) Chenguang Shen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The profile of peripheral blood lymphocyte subsets and serum cytokines in children with 2019 novel coronavirus pneumonia

(2020) Hui Li et al.   JOURNAL OF INFECTION

Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19

(2020) Yun Xie et al.   JOURNAL OF INFECTION

Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in Patients With Coronavirus Disease 2019

(2020) Qing-Lei Zeng et al.   JOURNAL OF INFECTIOUS DISEASES

ISTH interim guidance on recognition and management of coagulopathy in COVID‐19

(2020) Jecko Thachil et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Heparin resistance in COVID-19 patients in the intensive care unit

(2020) D. White et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Why tocilizumab could be an effective treatment for severe COVID-19?

(2020) Binqing Fu et al.   Journal of Translational Medicine

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

(2020) Fei Zhou et al.   LANCET

SARS-CoV-2 and viral sepsis: observations and hypotheses

(2020) Hui Li et al.   LANCET

Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19

(2020) Irani Thevarajan et al.   NATURE MEDICINE

Increased ACE2 Expression in the Bronchial Epithelium of COPD Patients who are Overweight

(2020) Andrew Higham et al.   Obesity

High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation

(2020) Arthur Simonnet et al.   Obesity

Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis

(2020) Jaber S. Alqahtani et al.   PLoS One

Effectiveness of convalescent plasma therapy in severe COVID-19 patients

(2020) Kai Duan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cytokine release syndrome in severe COVID-19

(2020) John B. Moore et al.   SCIENCE

Convalescent Plasma: Therapeutic Hope or Hopeless Strategy in the SARS-CoV-2 Pandemic

(2020) H. Cliff Sullivan et al.   TRANSFUSION MEDICINE REVIEWS

Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases

(2020) Cynthia Magro et al.   Translational Research

Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients

(2020) Jing Liu et al.   EBioMedicine

Interleukin‐6 blockade treatment for COVID‐19 associated cytokine release syndrome in a patient with poorly controlled chronic myeloid leukaemia

(2020) Amita Ranger et al.   BRITISH JOURNAL OF HAEMATOLOGY

Protective immunity after COVID-19 has been questioned: What can we do without SARS-CoV-2-IgG detection?

(2020) Juliana Gil Melgaço et al.   CELLULAR IMMUNOLOGY

Innate immunity in COVID-19 patients mediated by NKG2A receptors, and potential treatment using Monalizumab, Cholroquine, and antiviral agents

(2020) Ahmed Yaqinuddin et al.   MEDICAL HYPOTHESES

Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China

(2020) Xin Xu et al.   NATURE MEDICINE

Immune-mediated approaches against COVID-19

(2020) Helena F. Florindo et al.   Nature Nanotechnology

Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications

(2020) Divij Mathew et al.   SCIENCE

Severe COVID-19 infection associated with endothelial activation

(2020) Robert Escher et al.   THROMBOSIS RESEARCH

Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study

(2020) Danying Liao et al.   Lancet Haematology

Coagulation abnormalities and thrombosis in patients with COVID-19

(2020) Marcel Levi et al.   Lancet Haematology

Reappearance of effector T cells is associated with recovery from COVID-19

(2020) Ivan Odak et al.   EBioMedicine

SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection

(2020) Daniel M. Altmann et al.   Science Immunology

Immunosenescence exacerbates the COVID-19

(2020) Claudio Napoli et al.   ARCHIVES OF GERONTOLOGY AND GERIATRICS

Epigenetic susceptibility to severe respiratory viral infections: pathogenic and therapeutic implications: a narrative review

(2020) Ettore Crimi et al.   BRITISH JOURNAL OF ANAESTHESIA

Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19

(2020) et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19

(2020) Girish N. Nadkarni et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Update on the use of immunoglobulin in human disease: A review of evidence

(2017) Elena E. Perez et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

IL-6 down-regulates HLA class II expression and IL-12 production of human dendritic cells to impair activation of antigen-specific CD4+ T cells

(2016) Yosuke Ohno et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Inflammation and Immune Response in COPD: Where Do We Stand?

(2013) Nikoletta Rovina et al.   MEDIATORS OF INFLAMMATION

Neutralizing Antibodies and Pathogenesis of Hepatitis C Virus Infection

(2012) Samira Fafi-Kremer et al.   Viruses-Basel